Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: A prospective study-Reference-Cited by-同舟云学术

Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: A prospective study

Published:2011-03-21 Issue:4 Volume:26 Page:657-662
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:

Author:

Buchs Nicolas C,Bühler Leo,Bucher Pascal,Willi Jean-Pierre,Frossard Jean-Louis,Roth Arnaud D,Addeo Pietro,Rosset Antoine,Terraz Sylvain,Becker Christoph D,Ratib Osman,Morel Philippe

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2010.06525.x/fullpdf

Reference34 articles.

1. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma;Wagner;Br. J. Surg.,2004

2. Endosonography is superior to angiography in the preoperative assessment of vascular involvement among patients with pancreatic carcinoma;Ahmad;J. Clin. Gastroenterol.,2001

3. Pancreatic carcinoma: MR, MR angiography and dynamic helical CT in the evaluation of vascular invasion;Arslan;Eur. J. Radiol.,2001

4. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer;DeWitt;Ann. Intern. Med.,2004

5. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography;Soriano;Am. J. Gastroenterol.,2004

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quarter-Century PET/Computed Tomography Transformation of Oncology;PET Clinics;2024-04

2. Baseline Characteristics and Use of Pretherapeutic 18F-Fluorodeoxyglucose-PET for Pancreatic Cancer;Journal of the American College of Surgeons;2024-03-06

3. Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer;PET Clinics;2023-07

4. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-11

5. The Value of 18F-FDG PET/CT in Diagnosing Pancreatic Lesions: Comparison With CA19-9, Enhanced CT or Enhanced MR;Frontiers in Medicine;2021-10-08